IRE1α levels are controlled via intricate feedback loops that regulate its abundance during ER stress (Sun et al, 2015) and aberrant overexpression of IRE1α in multiple myeloma and breast cancer contributes to pathology (Harnoss et al, 2019; Harnoss et al, 2020). This evidence concerns the gene ERN1 and breast carcinoma.